HEALIUS LIMITED — Major Shareholding Notification 2017

Feb 21, 2017

Form 603

Corporations Act 2001 Section 671B

Notice of initial substantial holder

To Company Name/Scheme	Primary Health Care Limited
ACN/ARSN	064 530 516
1. Details of substantial holder (1)
Name	Harris Associates L.P.
ACN/ARSN (if applicable)
The holder became a substantial holder on	17/02/2017

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of securities (4)	Person's votes (5) Number of securities		Voting power (6)
Ordinary	27,338,638	27,338,638	5.24%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holder of relevant interest	Nature of relevant interest (7)	Class and number of securities common/27,338,638
Harris Associates L.P.	Investment Only

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)	Class and number of securities
See Annex A

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Date of acquisition			Class and number of securities
	Cash	Non-cash
			Consideration (9)

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN (if applicable)	Nature of association

7. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Harris Associates L.P.	111 S. Wacker Drive, Suite 4600, Chicago, IL 60606

Signature

print name	Kim Colwell		capacity	Senior Compliance Officer
		sign here Kunberly & Colwell	date	21/02/2017

DIRECTIONS

• If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the $(1)$ manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the form.
• See the definition of "associate" in section 9 of the Corporations Act 2001. $(2)$
• See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001. $(3)$
• $(4)$ The voting shares of a company constitute one class unless divided into separate classes.
• The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an $(5)$ associate has a relevant interest in.
• The person's votes divided by the total votes in the body corporate or scheme multiplied by 100. $(6)$
• Include details of: $(7)$
• any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of (a) any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
• any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or $(b)$ disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write $(8)$ "unknown".
• Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was $(9)$ acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

ANNEX A

HARRIS ASSOCIATES 17-Feb-17

			Nature of
Account	Security	Quantity	Investment	Class	Voting
Account 1	Primary Health Care		18,542,656 Investment	Ordinary		18,542,656
Account 2	Primary Health Care		3,955,525 Investment	Ordinary		3,955,525
Account 3	Primary Health Care		2,275,539 Investment	Ordinary		2,275,539
Account 4	Primary Health Care		503,814 Investment	Ordinary		503,814
Account 5	Primary Health Care		1,372,304 Investment	Ordinary		1,372,304
Account 6	Primary Health Care		319,900 Investment	Ordinary		319,900
Account 7	Primary Health Care		368,900 Investment	Ordinary		368,900

ANNEX B

$\lambda$

HARRIS ASSOCIATES From 10-17-16 To 02-17-17

	Trade
Trans	Date	Quantity	Security	Class	Principal
Buy	12/12/2016		84,600 Primary Health Care	Ordinary	245,971.72
Buy	12/12/2016		124,700 Primary Health Care	Ordinary	362,561.16
Buy	2/17/2017		267,800 Primary Health Care	Ordinary	682,053.31
Buy	2/17/2017		603,200 Primary Health Care	Ordinary	1,541,778.13
Buy	2/17/2017		335,400 Primary Health Care	Ordinary	853,013.65
Buy	2/17/2017		47,200 Primary Health Care	Ordinary	120,212.53
Buy	2/17/2017		106,200 Primary Health Care	Ordinary	271,447.01
Buy	2/17/2017		59,100 Primary Health Care	Ordinary	150,307.41
Buy	2/17/2017		41,800 Primary Health Care	Ordinary	106,459.40
Buy	2/17/2017		94,100 Primary Health Care	Ordinary	240,519.43
Buy	2/17/2017		52,400 Primary Health Care	Ordinary	133,267.49
Buy	2/17/2017		17,400 Primary Health Care	Ordinary	44,315.64
Buy	2/17/2017		39,100 Primary Health Care	Ordinary	99,939.53
Buy	2/17/2017		21,700 Primary Health Care	Ordinary	55,189.02
Buy	2/17/2017		3,200 Primary Health Care	Ordinary	8,150.00
Buy	2/17/2017		7,300 Primary Health Care	Ordinary	18,658.79
Buy	2/17/2017		4,000 Primary Health Care	Ordinary	10,173.09
Buy	2/17/2017		3,200 Primary Health Care	Ordinary	8,150.00
Buy	2/17/2017		7,400 Primary Health Care	Ordinary	18,914.39
Buy	2/17/2017		4,100 Primary Health Care	Ordinary	10,427.42